OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
17.85
+0.98 (5.81%)
Nov 21, 2025, 4:00 PM EST - Market closed
OrthoPediatrics Revenue
OrthoPediatrics had revenue of $61.25M in the quarter ending September 30, 2025, with 12.23% growth. This brings the company's revenue in the last twelve months to $227.41M, up 19.90% year-over-year. In the year 2024, OrthoPediatrics had annual revenue of $204.73M with 37.65% growth.
Revenue (ttm)
$227.41M
Revenue Growth
+19.90%
P/S Ratio
1.83
Revenue / Employee
$404,644
Employees
562
Market Cap
447.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 204.73M | 56.00M | 37.65% |
| Dec 31, 2023 | 148.73M | 26.44M | 21.62% |
| Dec 31, 2022 | 122.29M | 24.24M | 24.72% |
| Dec 31, 2021 | 98.05M | 26.97M | 37.95% |
| Dec 31, 2020 | 71.08M | -1.47M | -2.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
KIDS News
- 8 days ago - OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches - GlobeNewsWire
- 17 days ago - OrthoPediatrics to Participate in Upcoming Conferences - GlobeNewsWire
- 24 days ago - OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 24 days ago - OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family - GlobeNewsWire
- 5 weeks ago - OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025 - GlobeNewsWire
- 6 weeks ago - OrthoPediatrics Corp. (KIDS) Q3 2025 Sales Call Transcript - Seeking Alpha
- 6 weeks ago - OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance - GlobeNewsWire